Researchers have made a significant breakthrough in cardiovascular health by demonstrating that a new drug, UDP-003, can safely remove a harmful cholesterol byproduct known as 7-ketocholesterol from the human body. This compound is linked to atherosclerosis, a condition that leads to plaque buildup in arteries and increases the risk of heart attacks and strokes. The findings were presented at the American Heart Association’s Vascular Discovery Scientific Sessions, marking a potential shift in how cardiovascular diseases are treated, moving from merely managing symptoms to actively reversing plaque buildup.

This discovery is crucial for anyone looking to maintain heart health and reduce their risk of serious cardiovascular events. The study found that even a small reduction in coronary plaque can lower the risk of heart attacks or strokes by up to 25%. For people with a history of heart issues, this could mean a new way to protect their heart health and potentially reverse damage that has already occurred. The trial’s results indicate that UDP-003 can effectively promote the excretion of 7-ketocholesterol, which may lead to healthier arteries and improved overall cardiovascular function.

The research is still in its early stages, having been conducted as a first-in-human, randomized, double-blind, placebo-controlled trial. While the initial results are promising, they are based on a small cohort of participants and further studies are needed to confirm the drug’s effectiveness in larger populations. Cyclarity Therapeutics plans to continue developing UDP-003, with a Phase 2 trial expected to begin in 2026 to further assess its ability to promote plaque regression.

For those interested in improving cardiovascular health, staying informed about upcoming treatments like UDP-003 could be beneficial. While this drug is not yet widely available, maintaining a healthy lifestyle through regular exercise, a balanced diet, and routine health check-ups remains essential for heart health.

Source: lifespan.io